|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | Lymph node ratio and preoperative CA 19-9 levels predict overall survival and recurrence-free survival in patients with resected pancreatic adenocarcinoma显示文摘AIM:Clinicopathologic factors predicting overall survival (OS) would help identify a subset to benefit from adjuvant therapy. METHODS: One hundred and sixty-nine patients patients from 1984 to 2009 with curative resections for pancreatic adenocarcinoma were included. Tumors were staged by American Joint Committee on Cancer 7th edition criteria. Univariate and multivariable analyses were performed using Kaplan-Meier methodology or Cox proportional hazard models. Log-rank tests were performed. Statistical inferences were assessed by two-sided 5% significance level. RESULTS: Median age was 67.1 (57.2-73.0) years with equal gender distribution. Tumors were in the head (89.3%) or body/tail (10.7%). On univariate analysis, adjuvant therapy, lymph node (LN) ratio, histologic grade, negative margin status, absence of peripancreatic extension, and T stage were associated with improved OS. Adjuvant therapy, LN ratio, histologic grade, number of nodes examined, negative LN status, and absence of peripancreatic extension were associated with improved recurrence-free survival (RFS). On multivariable analysis, LN ratio and carbohydrate antigen (CA) 19-9 levels were associated with OS. LN ratio was associated with RFS. CONCLUSION: The LN ratio and CA 19-9 levels are independent prognostic factors following curative resections of pancreatic cancer. | Sabrina C Wentz Zhi-Guo Zhao Yu Shyr Chan-Juan Shi Kay Washington Nipun B Merchant Fen Xia A Bapsi Chakravarthy | 2012 | World Journal of Gastrointestinal Oncology2012，4，10： | 3 |
| 2 | Identification of human triple-negative breast cancer subtypes and preclinical models for selection of targeted therapies显示文摘 | Lehmann Brian D Bauer Joshua A Chen Xi Sanders Melinda E Chakravarthy A Bapsi Shyr Yu Pietenpol Jennifer A | 2011 | Journal of Clinical Investigation2011，，7： | 2 |
| 3 | Risk scoring for predicting mucosi- tis in Indian patients with esophageal carcinoma receiving concurrent che- moradiotherapy显示文摘 | Devaraju C J Lokanatha D Bapsy PP | 2009 | Gastrointest Cancer Res2009，3，1： | 1 |
| 4 | Gastrointestinal stromal tumour-a paradigm shift in management of solid tumors显示文摘 | Bapsy PP Prabhash K Babu KG | 2003 | JAPI2003，51，8： | 1 |
| 5 | Open-label,multi-center,non-randomized,single-arm study to evaluate the safety and efficacy of dendritic cell immunotherapy in patients with refractory solid malignancies,on supportive care显示文摘 | Bapsy PP Sharan B Kumar C | 2014 | Cytotherapy2014，16，2： | 1 |
| 6 | Efficacy and safety of granulocyte macrophage-colony stimulating factor(rhG-CSF) on the frequency and severity of radiation mucositis in patients with head and neck carcinomad显示文摘 | Kannan V Bapsy PP Anantha N | 1997 | Int J Radiat Biol Phys1997，15，： | 1 |
| 7 | Clinical outcome of adjuvant endocrine treatment according to Her-2/neu status in breast cancer显示文摘 | James R Thriveni K Krishnamoorthy L Deshmaue V Bapsy PP Ramaswamy G | 2011 | Indian J Med Res2011，133，： | 1 |
| 8 | Trastuzumab plus anastrozole versus anastrozole alone for the treatment of postmenopausal women with human epidermal growth factor receptor 2-positive, hormone receptor-positive metastatic breast cancer: results from the randomized phase III TANDEM study显示文摘 | Kaufman B Mackey JR Clemens MR Bapsy PP Vaid A Wardley A Tjulandin S Jahn M Lehle M Feyereislova A Revil C Jones A | 2009 | J Clin Oncol2009，27，33： | 1 |
| 9 | Deletion of 6q23 as sole abnormality in acute myelocytic leukemia 显示文摘 | Sundareshan TS Prabhash K Bapsy PP | 2003 | Cancer Genet Cytogenet2003，143，1： | 1 |
| 10 | Risk scoring for predicting mucositis in indian patients with esophageal carcinoma re- ceiving concurrent chemoradiotherapy 显示文摘 | Devarju CJ Dasappa Lokanatha Bapsy PP | 2009 | Gastrointestinal Cancer Research2009，3，1： | 1 |
| 11 | Gastrointestinal stromal tumors - a paradigm shift in management of solid tumors 显示文摘 | Bapsy PP Prabhash K Babu KG | 2003 | J Assoc Physicians India2003，51，： | 1 |
| 12 | Efficacy and safety of granulocyte macrophage-colony stimulating factor on the frequency and severity of radiation mucositis in patients with head and neck carcinoma显示文摘 | Kannan V Bapsy PP Anantha N | | 0，，05： | 1 |
| 13 | Risk scoring for predicting mucositis in Indian patients with esophageal car- cinoma receiving concurrent chemoradiotherapy 显示文摘 | DEVARAJU C J LOKANATHA D BAPSY P P | 2009 | Gastroint- est Cancer Res2009，3，1： | 1 |
您所在的机构暂未开通此部分的功能，请联系管理员